Moreover, in a clinical study of chronic lymphocytic leukemia (CLL), the expression of CD59 but not CD55 significantly increased in patients who failed to clear CLL cells from circulation after rituximab treatment (19). The gene discussed is CD59; the disease is B-cell chronic lymphocytic leukemia.